Glaukos Total Liabilities 2014-2025 | GKOS
Glaukos total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Glaukos total liabilities for the quarter ending September 30, 2025 were $0.230B, a 10.93% decline year-over-year.
- Glaukos total liabilities for 2024 were $0.208B, a 56.58% decline from 2023.
- Glaukos total liabilities for 2023 were $0.479B, a 1.33% increase from 2022.
- Glaukos total liabilities for 2022 were $0.472B, a 2.13% increase from 2021.
|
Glaukos Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $208 |
| 2023 | $479 |
| 2022 | $472 |
| 2021 | $463 |
| 2020 | $338 |
| 2019 | $145 |
| 2018 | $33 |
| 2017 | $28 |
| 2016 | $17 |
| 2015 | $21 |
| 2014 | $30 |
| 2013 | $24 |
|
Glaukos Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $230 |
| 2025-06-30 | $222 |
| 2025-03-31 | $202 |
| 2024-12-31 | $208 |
| 2024-09-30 | $258 |
| 2024-06-30 | $255 |
| 2024-03-31 | $483 |
| 2023-12-31 | $479 |
| 2023-09-30 | $471 |
| 2023-06-30 | $468 |
| 2023-03-31 | $464 |
| 2022-12-31 | $472 |
| 2022-09-30 | $460 |
| 2022-06-30 | $469 |
| 2022-03-31 | $455 |
| 2021-12-31 | $463 |
| 2021-09-30 | $463 |
| 2021-06-30 | $459 |
| 2021-03-31 | $433 |
| 2020-12-31 | $338 |
| 2020-09-30 | $333 |
| 2020-06-30 | $333 |
| 2020-03-31 | $138 |
| 2019-12-31 | $145 |
| 2019-09-30 | $117 |
| 2019-06-30 | $114 |
| 2019-03-31 | $43 |
| 2018-12-31 | $33 |
| 2018-09-30 | $27 |
| 2018-06-30 | $23 |
| 2018-03-31 | $20 |
| 2017-12-31 | $28 |
| 2017-09-30 | $21 |
| 2017-06-30 | $20 |
| 2017-03-31 | $15 |
| 2016-12-31 | $17 |
| 2016-09-30 | $19 |
| 2016-06-30 | $19 |
| 2016-03-31 | $18 |
| 2015-12-31 | $21 |
| 2015-09-30 | $23 |
| 2015-06-30 | $33 |
| 2015-03-31 | $33 |
| 2014-12-31 | $30 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.331B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.085B | 27.10 |
| Intuitive Surgical (ISRG) | United States | $201.399B | 78.80 |
| IDEXX Laboratories (IDXX) | United States | $57.017B | 56.62 |
| Edwards Lifesciences (EW) | United States | $48.652B | 32.62 |
| IQVIA Holdings (IQV) | United States | $41.139B | 22.94 |
| Alcon (ALC) | Switzerland | $38.961B | 26.33 |
| Mettler-Toledo (MTD) | United States | $30.332B | 35.49 |
| DexCom (DXCM) | United States | $27.399B | 37.77 |
| STERIS (STE) | Ireland | $25.505B | 26.33 |
| Waters (WAT) | United States | $23.464B | 31.03 |
| Coloplast (CLPBY) | Denmark | $20.125B | 34.35 |
| Hologic (HOLX) | United States | $16.689B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.475B | 0.00 |
| Globus Medical (GMED) | United States | $12.067B | 25.33 |
| Penumbra (PEN) | United States | $11.787B | 82.91 |
| Masimo (MASI) | United States | $6.974B | 22.35 |
| Sysmex ADR (SSMXY) | Japan | $6.289B | 19.98 |
| TransMedics (TMDX) | United States | $4.877B | 57.78 |
| Teleflex (TFX) | United States | $4.592B | 7.32 |
| Veracyte (VCYT) | United States | $3.403B | 38.78 |
| LivaNova (LIVN) | United Kingdom | $3.349B | 18.09 |
| Integer Holdings (ITGR) | United States | $2.899B | 13.61 |
| Alphatec Holdings (ATEC) | United States | $2.444B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.366B | 22.14 |
| Nihon Kohden (NHNKY) | Japan | $2.034B | 17.76 |
| Artivion (AORT) | United States | $2.032B | 93.26 |
| UFP Technologies (UFPT) | United States | $1.947B | 25.71 |
| PROCEPT BioRobotics (PRCT) | United States | $1.709B | 0.00 |
| AxoGen (AXGN) | United States | $1.427B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.417B | 0.00 |
| IRadimed (IRMD) | United States | $1.263B | 60.15 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.961B | 5.21 |
| Pulse Biosciences (PLSE) | United States | $0.959B | 0.00 |
| SiBone (SIBN) | United States | $0.776B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.760B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.669B | 38.90 |
| Pacific Biosciences Of California (PACB) | United States | $0.643B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.586B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.556B | 0.00 |
| NeuroPace (NPCE) | United States | $0.537B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.56 |
| OrthoPediatrics (KIDS) | United States | $0.469B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.466B | 12.86 |
| RxSight (RXST) | United States | $0.416B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.368B | 61.29 |
| Sight Sciences (SGHT) | United States | $0.361B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.199B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.185B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| CVRx (CVRX) | United States | $0.160B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Solana (HSDT) | United States | $0.142B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| LENSAR (LNSR) | United States | $0.140B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.135B | 0.00 |
| Neuronetics (STIM) | United States | $0.123B | 0.00 |
| Hyperfine (HYPR) | United States | $0.111B | 0.00 |
| Accuray (ARAY) | United States | $0.098B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |